Brief: Cyclo Therapeutics Announces Execution Of Definitive Agreement With Rafael Holdings Providing For $5.0 Million Of Additional Funding Via A Private Placement
June 5 (Reuters) - Cyclo Therapeutics Inc CYTH.O :
* CYCLO THERAPEUTICS ANNOUNCES EXECUTION OF DEFINITIVE
AGREEMENT
WITH RAFAEL HOLDINGS, INC. PROVIDING FOR $5.0 MILLION OF
ADDITIONAL FUNDING VIA A PRIVATE PLACEMENT
* CYCLO THERAPEUTICS - WARRANTS WILL HAVE AN EXERCISE PRICE
OF
$1.25 AND A TERM OF SEVEN YEARS
Source text for Eikon: ID:nBw36BStja
Further company coverage: CYTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rafael Holdings
See all newsBrief: Rafael Holdings Announces Topline Results From The Pivotal Phase 3 Transportnpc™ Study Of Trappsol® Cyclo™ In Niemann-Pick Disease Type C (Npc)
Israel expects new air defence orders from Europe due to Russia concerns
Biotech firm Rafael's Q3 net loss narrows; set to submit NDA for Trappsol Cyclo in H2
Rafael Holdings Q2 net loss widens on consolidation of Cyclo Therapeutic's costs
Brief: Rafael Holdings Q2 Net Income USD -6.327 Million